Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Avecho Biotechnology Limited ( (AU:AVE) ) just unveiled an announcement.
Avecho Biotechnology Limited has applied to the ASX for quotation of new ordinary fully paid shares following the issue of additional securities. The company will have 1,807,146 new shares quoted from 4 May 2026 and a further 5,193,571 shares quoted from 6 May 2026, reflecting the conversion or exercise of existing options or other convertible securities.
More about Avecho Biotechnology Limited
Avecho Biotechnology Limited is an Australian-listed company in the biotechnology sector, trading on the ASX under the code AVE. The company issues ordinary fully paid shares and is subject to the ASX Listing Rules governing the quotation of its securities in the public market.
Average Trading Volume: 8,888,198
Technical Sentiment Signal: Sell
Current Market Cap: A$44.08M
For detailed information about AVE stock, go to TipRanks’ Stock Analysis page.